ANVS - What's Going With Annovis Bio Shares Tuesday? | Benzinga
Annovis Bio, Inc (NYSE:ANVS) stock is trending Tuesday. The company eelier announced new data from its Phase III Parkinson’s study.
What Happened: The study showed improvements on the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) following treatment with buntanetap.
The findings demonstrated that the placebo group experienced cognitive deterioration throughout ...